Clinical trial

A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation

NCT02672839

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-02-01

PhasePHASE1

Study timeline

Study start (unknown)2016-02-01Date precision: month

Registry last updated2016-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitus (T2DM)unresolved

Interventions

LGD-6972 SolutionDRUG

LGD-6972 CapsulesDRUG

Sponsors & collaborators

Ligand Pharmaceuticalslead sponsor

Medpace, Inc.collaborator

Mapped research locations

CincinnatiOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02672839 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.